Impact Biotech
About
ImPact Biotech is focused on the development and launch of Padeliporfin VTP (Vascular Targeted Photodynamic) therapy for the treatment of solid tumors. The company is headquartered in Israel, with presence in Luxembourg, France and USA, as well as its own GMP-certified (Good Manufacturing Practice) facility and research center in Israel.
Tags
Total Employees
31
Current headcount
Score Breakdown
25Traction
47Team
0Visibility
14Profile
50Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Impact Biotech do?
ImPact Biotech is focused on the development and launch of Padeliporfin VTP (Vascular Targeted Photodynamic) therapy for the treatment of solid tumors. The company is headquartered in Israel, with presence in Luxembourg, France and USA, as well as its own GMP-certified (Good Manufacturing Practice) facility and research center in Israel.
How much funding has Impact Biotech raised?
Impact Biotech has raised a total of $3M in funding. The most recent round on record is Grant.
When was Impact Biotech founded?
Impact Biotech was founded in 1996.
What industry does Impact Biotech operate in?
Impact Biotech operates in Life Sciences, Cancer, Therapeutics.
How many employees does Impact Biotech have?
Impact Biotech has approximately 31 people on record.